Bruker (BRKR) Competitors

Mettler-Toledo International presently has a consensus price target of $1,446.36, indicating a potential downside of 4.32%. Bruker has a consensus price target of $57.00, indicating a potential downside of 11.19%. Given Mettler-Toledo International's higher probable upside, research analysts clearly believe Mettler-Toledo International is more favorable than Bruker.

95.1% of Mettler-Toledo International shares are owned by institutional investors. Comparatively, 79.5% of Bruker shares are owned by institutional investors. 0.7% of Mettler-Toledo International shares are owned by company insiders. Comparatively, 27.2% of Bruker shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Mettler-Toledo International has higher revenue and earnings than Bruker. Bruker is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks.

Mettler-Toledo International has a net margin of 21.91% compared to Bruker's net margin of -2.35%. Bruker's return on equity of 12.47% beat Mettler-Toledo International's return on equity.

In the previous week, Bruker had 7 more articles in the media than Mettler-Toledo International. MarketBeat recorded 13 mentions for Bruker and 6 mentions for Mettler-Toledo International. Mettler-Toledo International's average media sentiment score of 0.62 beat Bruker's score of 0.46 indicating that Mettler-Toledo International is being referred to more favorably in the media.

Mettler-Toledo International has a beta of 1.22, indicating that its stock price is 22% more volatile than the broader market. Comparatively, Bruker has a beta of 1.26, indicating that its stock price is 26% more volatile than the broader market.

Revvity has a net margin of 8.16% compared to Bruker's net margin of -2.35%. Bruker's return on equity of 12.47% beat Revvity's return on equity.

In the previous week, Revvity had 5 more articles in the media than Bruker. MarketBeat recorded 18 mentions for Revvity and 13 mentions for Bruker. Revvity's average media sentiment score of 0.49 beat Bruker's score of 0.46 indicating that Revvity is being referred to more favorably in the media.

Revvity currently has a consensus target price of $116.57, indicating a potential downside of 22.72%. Bruker has a consensus target price of $57.00, indicating a potential downside of 11.19%. Given Bruker's stronger consensus rating and higher probable upside, analysts clearly believe Bruker is more favorable than Revvity.

Revvity has higher earnings, but lower revenue than Bruker. Bruker is trading at a lower price-to-earnings ratio than Revvity, indicating that it is currently the more affordable of the two stocks.

Revvity has a beta of 1.09, meaning that its stock price is 9% more volatile than the broader market. Comparatively, Bruker has a beta of 1.26, meaning that its stock price is 26% more volatile than the broader market.

86.7% of Revvity shares are held by institutional investors. Comparatively, 79.5% of Bruker shares are held by institutional investors. 0.9% of Revvity shares are held by insiders. Comparatively, 27.2% of Bruker shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Revvity pays an annual dividend of $0.28 per share and has a dividend yield of 0.2%. Bruker pays an annual dividend of $0.20 per share and has a dividend yield of 0.3%. Revvity pays out 13.3% of its earnings in the form of a dividend. Bruker pays out -28.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Bruker is clearly the better dividend stock, given its higher yield and lower payout ratio.

Thermo Fisher Scientific has a net margin of 15.04% compared to Bruker's net margin of -2.35%. Thermo Fisher Scientific's return on equity of 17.09% beat Bruker's return on equity.

In the previous week, Thermo Fisher Scientific had 10 more articles in the media than Bruker. MarketBeat recorded 23 mentions for Thermo Fisher Scientific and 13 mentions for Bruker. Thermo Fisher Scientific's average media sentiment score of 0.95 beat Bruker's score of 0.46 indicating that Thermo Fisher Scientific is being referred to more favorably in the news media.

Bruker has a beta of 1.26, suggesting that its share price is 26% more volatile than the broader market. Comparatively, Thermo Fisher Scientific has a beta of 0.85, suggesting that its share price is 15% less volatile than the broader market.

Thermo Fisher Scientific has higher revenue and earnings than Bruker. Bruker is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks.

Bruker currently has a consensus price target of $57.00, suggesting a potential downside of 11.19%. Thermo Fisher Scientific has a consensus price target of $628.78, suggesting a potential downside of 6.78%. Given Thermo Fisher Scientific's stronger consensus rating and higher possible upside, analysts clearly believe Thermo Fisher Scientific is more favorable than Bruker.

79.5% of Bruker shares are held by institutional investors. Comparatively, 89.2% of Thermo Fisher Scientific shares are held by institutional investors. 27.2% of Bruker shares are held by insiders. Comparatively, 0.3% of Thermo Fisher Scientific shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Bruker pays an annual dividend of $0.20 per share and has a dividend yield of 0.3%. Thermo Fisher Scientific pays an annual dividend of $1.88 per share and has a dividend yield of 0.3%. Bruker pays out -28.6% of its earnings in the form of a dividend. Thermo Fisher Scientific pays out 10.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Thermo Fisher Scientific has raised its dividend for 8 consecutive years. Bruker is clearly the better dividend stock, given its higher yield and lower payout ratio.

Waters has a net margin of 3.58% compared to Bruker's net margin of -2.35%. Bruker's return on equity of 12.47% beat Waters' return on equity.

In the previous week, Waters had 4 more articles in the media than Bruker. MarketBeat recorded 17 mentions for Waters and 13 mentions for Bruker. Bruker's average media sentiment score of 0.46 beat Waters' score of 0.44 indicating that Bruker is being referred to more favorably in the news media.

Waters currently has a consensus target price of $434.60, indicating a potential upside of 0.14%. Bruker has a consensus target price of $57.00, indicating a potential downside of 11.19%. Given Waters' stronger consensus rating and higher possible upside, analysts plainly believe Waters is more favorable than Bruker.

Waters has higher earnings, but lower revenue than Bruker. Bruker is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks.

94.0% of Waters shares are owned by institutional investors. Comparatively, 79.5% of Bruker shares are owned by institutional investors. 0.3% of Waters shares are owned by insiders. Comparatively, 27.2% of Bruker shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Waters has a beta of 1.19, meaning that its stock price is 19% more volatile than the broader market. Comparatively, Bruker has a beta of 1.26, meaning that its stock price is 26% more volatile than the broader market.